Tower Research Capital LLC (TRC) - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 23 filers reported holding ALZAMEND NEURO INC in Q4 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q3 2023$11,519
+31.2%
48,605
+182.3%
0.00%
Q2 2023$8,782
+73083.3%
17,220
-40.9%
0.00%
Q1 2023$12
+20.0%
29,146
+72.0%
0.00%
Q4 2022$10
-99.9%
16,941
+11.0%
0.00%
Q2 2022$13,000
-13.3%
15,266
+24.6%
0.00%
Q1 2022$15,000
-81.7%
12,249
-53.8%
0.00%
-100.0%
Q3 2021$82,000
+355.6%
26,541
+1197.8%
0.00%
Q2 2021$18,0002,0450.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q4 2021
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders